Andrea D'ambrosio
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention.
Journal: The American journal of cardiology
Published: October 14, 2013
Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.)
Published: September 20, 2013
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
Journal: The American journal of cardiology
Published: December 21, 2012
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
Journal: The American journal of cardiology
Published: December 18, 2012
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study.
Journal: Journal of the American College of Cardiology
Published: September 19, 2012
Percutaneous closure of patent foramen ovale in a patient with situs viscerum inversus.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.)
Published: May 22, 2012
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study.
Journal: International journal of cardiology
Published: April 01, 2012
Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
Journal: The American journal of cardiology
Published: February 17, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026